Later Verstovsek et al. found the level of HGF in AML and MDS patients correlated with white blood cell and monocyte counts; high levels of HGF were also associated with shorter survival in AML, but not in MDS [96]. The gene discussed is HGF; the disease is myelodysplastic syndrome.